Bridging the Gap: Practical Implications for Optimizing Combination Antiretroviral Therapy [International Conference on AIDS (12th: 1998: Geneva, Switzerland)]

I I I I I I I I

Practical Implications
An Official Sat
Monday, June 2
Course Director
Paul Volberding, MD
Professor of Medicine
Director, Center for AIDS Research
University of California, San Francisco
Director, AIDS Program and Medical 0O
San Francisco General Hospital
San Francisco, California

(esearc

Bridging the Gap:
for Optimizing Combination Antiretroviral Therapy
ellite Sy iu m ~of e 12th World AIDS Conference
9, 1998 * 0 am 8:30 a Palexpo * Geneva, Switzerland
Agenda
Monday * June 29,1998
6:15 am - 6:30 am
Registration and Continental Breakfast
ncology
S6:30 am - 6:35 am
Welcome and Opening Remarks
Paul Volberding, MD
6:35 am - 7:00 am
HIV Pathogenesis: Upa on Eradication Hypothesis
h Center David D. Ho, MD
7:00 am - 7:25M
Role of New Tec lgies in Managing
Antiretroviral Therapy
hology John W Mellors, MD
Medical Center::
7:25 am - )am
Antiretroviral Treatment Strategies:
Lessons from ART History
Michael S. Saag, MD
7:50 am - 8:00 am,
The Pharmacoeconomic pact of Protease Inhibitors
John Stansell, MD ^
8:00 am - 8:10 am
Community Implications: Bridging the Gap;:;
Dawn Averitt
8:10am - 8:30 am
Panel Discussion
Moderator: Paul Volberding, MD
8:30 am
Adjourn

arat
airs

Dawn Averitt
Founder of Women's Information
Service & Exchange (WISE)
Atlanta, Georgia

Meeting and Location Information
"Brii the Gap: Practical Implications for
S"tion Antiretriral Therapy"
is ano fi osiumbwosddinum
s ~ ~~~~ ~'"~"-~ TT ' fj s81 a

Acknowledgement
Bridging the Gap Practical Implications
for Optimizing Combiation Antiretroviral
Therapy" is supported by an
unrestricted educatonal grant from
Agorn Pharmaceuticals,Inc.